Unihealth Hospitals Ltd

Unihealth Hosp Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Unihealth Hospitals Ltd

₹ 173 1.76%
08 Jul 11:00 a.m.
Company website NSE - SME: UNIHEALTH
About

Incorporated in 2010, Unihealth Consultancy Ltd is in the business of Medical Tour Operator and Health Consultancy Service & Trader in Medical Equipments[1]

Key Points

Business Overview:[1]
Headquartered in Mumbai, Unihealth Hospitals Ltd is a diversified healthcare service provider with a global presence, particularly in Africa. The company operates under the 'UMC Hospitals' brand and provides:
- Hospital and medical centre services,
- Healthcare consultancy and project management,
- Export and distribution of pharmaceutical and medical consumables,
- Medical value travel facilitation for international patients.

Website NSE - SM
  • Market Cap ₹ 266 Cr.
  • Current Price ₹ 173
  • High / Low ₹ 191 / 109
  • Stock P/E 17.6
  • Book Value ₹
  • Dividend Yield 0.00 %
  • ROCE 17.2 %
  • ROE 16.0 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has delivered good profit growth of 75.9% CAGR over last 5 years

Cons

  • Company has high debtors of 328 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Edit Columns
Loading peers table ...

Half Yearly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2023 Mar 2024 Sep 2024 Mar 2025
22 27 24 32
15 16 16 21
Operating Profit 7 10 8 11
OPM % 32% 39% 33% 33%
1 1 1 1
Interest 2 2 1 1
Depreciation 1 1 1 1
Profit before tax 5 8 7 10
Tax % 17% 28% 29% 1%
4 6 5 10
EPS in Rs
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
22 26 37 44 49 56
20 20 25 30 31 37
Operating Profit 2 7 12 14 18 18
OPM % 10% 25% 31% 31% 36% 33%
1 2 1 2 2 3
Interest 2 1 5 4 3 2
Depreciation 2 2 2 3 2 2
Profit before tax -1 5 5 9 14 17
Tax % 2% 9% 27% 17% 24% 12%
-1 5 4 8 10 15
EPS in Rs
Dividend Payout % 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 20%
3 Years: 15%
TTM: 14%
Compounded Profit Growth
10 Years: %
5 Years: 76%
3 Years: 60%
TTM: 47%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 36%
Return on Equity
10 Years: %
5 Years: 22%
3 Years: 19%
Last Year: 16%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 1 1 1 1 15 15
Reserves 4 9 13 26 70 88
41 39 38 39 15 13
12 9 12 12 10 16
Total Liabilities 58 58 65 78 110 132
35 35 36 37 36 40
CWIP 2 0 0 0 0 5
Investments 0 0 0 0 0 0
20 22 28 41 74 87
Total Assets 58 58 65 78 110 132

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
1 4 9 1 5 -3
-1 0 -3 -5 0 -4
1 -3 -6 3 22 -3
Net Cash Flow 0 1 0 -0 27 -10

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 206 198 180 228 251 328
Inventory Days 50 86 78 98 88 64
Days Payable 382 91 79 137 104 86
Cash Conversion Cycle -125 192 180 188 235 306
Working Capital Days 114 162 146 170 228 322
ROCE % 14% 20% 22% 20% 17%

Shareholding Pattern

Numbers in percentages

2 Recently
Sep 2023Mar 2024Sep 2024Mar 2025
68.80% 68.80% 68.93% 68.93%
5.61% 0.00% 0.00% 0.00%
3.31% 0.14% 0.02% 0.23%
22.27% 31.05% 31.05% 30.83%
No. of Shareholders 1,111979984985

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls